Resources

Categories
  1. When will Opzelura be available in the UK (and what to do in the meantime)?

    All vitiligo patients in the UK should know about Opzelura avaiability on the market, and the alternatives in the meantime.

    Read more »
  2. Briumvi vs Ocrevus vs Kesimpta: Understanding Your MS Treatment Options

    Understand the similarities and differences between Briumvi, Ocrevus and Kesimpta in one simple overview.

    Read more »
  3. Can Jakavi be used instead of Opzelura? The short-but-full story.

    Can you use Jakavi for your vitiligo, while waiting for Opzelura to become available on the European market? All you need to know.

    Read more »
  4. Can Leqembi be administered at home? Home infusions, autoinjectors, and more.

    Is it possible to get a Leqembi home infusion? Will you be able to inject Leqembi at home by yourself soon? Learn all we know.

    Read more »
  5. What’s the difference between Leqembi and Aduhelm? A simple overview.

    The difference between Leqembi and Aduhelm, simply explained. How do these Alzheimer's medicines work, where are they approved, and how can you access them?

    Read more »
  6. Changing the story: How nitisinone brings hope back for HT-1 and AKU patients

    How nitisinone tablets give hope to HT-1 and AKU patients. Now also available for free in India, Pakistan, Bangladesh and Sudan.

    Read more »
  7. Charting the Course: A Clear Guide to Alzheimer's Treatment by Stage

    Find hope and support with Alzheimer's treatment options. Learn about innovative therapies and resources to manage symptoms and improve quality of life.

    Read more »
  8. Your complete guide to Briumvi, the newest approved MS treatment

    Everything you need to know about Briumvi, the latest approved CD20 antibody for the treatment of multiple sclerosis.

    Read more »
  9. Breakthrough or hype? A simple look at anti-amyloid therapy for Alzheimer's disease.

    Anti-amyloid therapy for Alzheimer's, explained simply. What is it, how does it work, which one is approved, and how can you access it?

    Read more »
  10. How to access Leqembi before its EMA approval

    All the safe and legal options to access Leqembi while it's waiting for its EU approval.

    Read more »
  11. Your Complete Guide to Leqembi: An Alzheimer's Drug Worth Remembering

    All you need to know about Leqembi, the latest approved Alzheimer's medicine.

    Read more »
  12. Emerging NSCLC treatments: Here are the latest drugs to keep an eye on

    A simple overview of standard and emerging NSCLC treatments.

    Read more »
  13. KRAS inhibitors for lung cancer: All about the new treatments bringing hope

    Understanding KRAS inhibitors for lung cancer: how they work, which ones are approved, and what's coming?

    Read more »
  14. What's the difference between Sotorasib and Adagrasib? A simple overview.

    Sotorasib vs Adagrasib: A side-by-side comparison of the latest Alzheimer's medicines.

    Read more »
  15. Your complete guide to Lumakras (sotorasib) and how to get it

    Anti-amyloid therapy for Alzheimer's, explained simply. What is it, how does it work, which one is approved, and how can you access it?

    Read more »
  16. Press release: Partnership with ATOM Coalition

    Amsterdam's online medicine platform Everyone.org offers affordable cancer medicines for patients in poorest countries thanks to partnership with ATOM coalition in Geneva.

    Read more »
  17. TheSocialMedwork is now Everyone.org

    Medicines should be available to everyone, no matter who you are or where you live. At TheSocialMedwork, for the past 7 years, we have been helping patients and their physicians access medicines not yet available where they live.

    Read more »
  18. The Medicine Access Masterclass is coming soon

    The Medicine Access Masterclass is a unique overview of early medicine access options of innovative medicine which cannot be found anywhere else.

    Read more »
  19. What we know about Paxlovid (nirmatrelvir and ritonavir): oral antiviral against COVID-19 | New COVID-19 Medicine

    Paxlovid is an antiviral administered orally to patients who are ill with COVID-19 or have been exposed to the coronavirus SARS-CoV-2 and are at risk of developing severe illness. The manufacturer, pharmaceutical and biotechnology giant Pfizer, developed it to patients avoid severe illness which can lead to hospitalization and death. It is meant to be administered at the first sign of infection.

    Read more »
  20. New COVID-19 Treatments 2021

    The SARS-CoV-2 virus is spread through human-to-human transmission. Coughing and sneezing produces small droplets, which can be breathed in by someone else who then becomes infected. The droplets can also be passed on via hand contact, for example if someone touches their nose or face and then shakes hands.

    Read more »
  21. All about Lagevrio (molnupiravir): the first oral antiviral against COVID-19 | New COVID-19 Medicine

    Molnupiravir is an orally administered antiviral medication that inhibits the replication of certain RNA viruses, and is used to treat COVID-19.

    Read more »
  22. Mari Carmen’s story: “I advise family unity when supporting a loved one who has ALS”

    Mari Carmen is the older sister of patient Juan Manuel, she takes care of her brother along with his wife. He was diagnosed with ALS in February 2020 and since then he has followed a clinical trial that includes Ketas (Ibudilast) which is not yet approved in Spain, where Juan Manuel lives.

    Read more »
  23. New Non-Hodgkin Lymphoma Treatments 2022

    Non-Hodgkin lymphoma (also called non-Hodgkin's lymphoma, NHL, or sometimes just lymphoma) is a type of cancer that starts in white blood cells known as lymphocytes. These cells are part of the body's immune system and they help the body fight infections.

    Read more »
  24. Mislav’s Story: “The more time I have, the higher the chance that some new more effective drug will be developed”

    Mislav was diagnosed with Grade II astrocytoma, a type of brain tumour, in 2018 and has struggled with the Croatian healthcare system to obtain a treatment, Fycompa, which was not approved in Croatia. TheSocialMedwork was able to help him access the medicine and he is now one of the patients that we are happy to not have anymore: the hospital where he is being treated has approved the import and treatment of Fycompa to him for free.

    Read more »
  25. New Asthma Treatments 2022

    Bronchial asthma (also known as asthma) is a pulmonary disease, in which the airways narrow, swell and produce more mucus than necessary.

    Read more »
  26. New Iron Deficiency Anemia Treatments 2022

    Iron deficiency is a state where the body lacks iron. It is the most common nutritional disorder in the world.

    Read more »
  27. New Multiple Myeloma Treatments 2022

    Multiple myeloma is a type of bone marrow cancer. Bone marrow is the soft tissue inside bones that produces the body's blood cells, including a type of white blood cell called plasma cell. Plasma cells play an important role in the immune system: they produce antibodies that help the body fight off germs.

    Read more »
  28. New Neuroblastoma Treatments 2022

    Neuroblastoma is a type of cancer that is formed by nerve cells called neuroblasts. Usually, these very early forms of nerve cells develop into adult nerve cells, but in neuroblastoma these cells develop into cancer cells instead. This type of cancer occurs most commonly in infants and young children. Neuroblastoma normally forms in the fetus, before a child is born.

    Read more »
  29. New Bladder Cancer Treatments 2022

    Bladder cancer - or urothelial cancer - most often begins in the cells that line the inside of the bladder, called urothelial cells. Urothelial cells are also found in other parts of the urinary system, such as the kidneys and the ureters. Urothelial cancer is found much more often in the bladder than in the other parts. But because people sometimes have tumors in these places, too, all of the urinary tract needs to be checked for tumors.

    Read more »
  30. New Spinal Muscular Atrophy Treatments 2022

    Spinal Muscular Atrophy (SMA) is an inherited disorder that affects nerves and muscles, which causes muscles to become increasingly weak. The cause is a shortage of the protein SMN, or ‘survival of motor neuron’. This protein is crucial for the function of nerves that control muscle activity. Without this protein, the motor neuron cells shrink and eventually die. This leads to muscle weakness seen in SMA..

    Read more »
US 0